Skip to content

Demonstration study for Appropriate Technique for Cervical Cancer Screening in China

Demonstration study for Appropriate Technique for Cervical Cancer Screening in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022530
Enrollment
Unknown
Registered
2019-04-15
Start date
2015-03-18
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer and Precancerous Lesions

Interventions

Gold Standard:Pathological examination
Index test:1.HPV&#32
test&#32
31,000&#32
women
2.Cytology&#32
diagnosis&#32
21,000&#32
3.VIA/VILI&#32
11,000&#32
women. Three&#32
results&#32
be&#32
with&#32
the&#32

Sponsors

Peking Union Medica College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Women aged between 35-64 yrs old; 2. with complete cervix; 3. Understand the research process, voluntary participation.

Exclusion criteria

Exclusion criteria: 1. With history of cervical cancer or hysterectomy; 2. With clinical symptoms of pregnancy; 3. Could not understand the study procedures or voluntarily participated.

Design outcomes

Primary

MeasureTime frame
CIN2+ Detection rate, Positive predictive value, False negative rate, Negative predictive value, Early diagnosis rate;Positive rate of primary screening tests;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactJinghe Lang

Peking Union Medical College Hospital

langjh@hotmail.com+86 13693328258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026